Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer

NCT07273396 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Neoplasms
Peritoneal Neoplasms

Interventions

DRUG: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) using paclitaxel

Sponsor

Seoul National University Hospital